Utility of Tc-99m GSA whole-body scintigraphy in detecting bone metastasesfrom hepatocellular carcinoma

Citation
K. Sueyoshi et al., Utility of Tc-99m GSA whole-body scintigraphy in detecting bone metastasesfrom hepatocellular carcinoma, CLIN NUCL M, 26(3), 2001, pp. 221-224
Citations number
14
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
CLINICAL NUCLEAR MEDICINE
ISSN journal
03639762 → ACNP
Volume
26
Issue
3
Year of publication
2001
Pages
221 - 224
Database
ISI
SICI code
0363-9762(200103)26:3<221:UOTGWS>2.0.ZU;2-O
Abstract
Recent advances in the treatment of hepatocellular carcinoma (HCC) have pro longed patient survival, However, the number of patients with bone metastas es identified during follow-up examinations has increased. Tc-99m Sn-N-pyri doxy-5-methyltryptophan (Tc-99m PMT) has been reported to accumulate at a h igh rate in HCC lesions and bone metastases, In the patient described here, whole-body scintigraphy showed accumulation of DTPA galactosyl human serum albumin (Tc-99m GSA) and Tc-99m PMT in bone metastases from HCC. The autho rs suggest that asialoglycoprotein receptors may be present in bone metasta ses from well-differentiated HCC, Tc-99m GSA whole-body imaging can be used to detect bone metastases from HCC and to evaluate hepatic reserve.